4
Changes in Ownership
Korro Bio, Inc. Filed Acc 0001127602-23-020819
Chief Scientific Officer sold 2,235 shares at an average $0.47 ($1,053)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Loose Christopher R. · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-07-13 | Sale : show line 1 in the form 10b5-1 | −1,329 | $0.39 | $518 | 198,358 | D |
| 2023-07-14 | Sale : show line 2 in the form 10b5-1 | −906 | $0.59 | $535 | 197,452 | D |
| Open-market sales · 2,235 sh · avg $0.47 · $1,053 | ||||||
Loading xslF345X05/form4.xml…